FITB
50
-8
AEE
73
-3
HON
49
-9
PM
49
4
MA
53
7
SCHW
56
3
CHD
29
-3
IFF
33
-11
EFX
55
-3
FLR
33
-5
V
36
4
VIX
40
-12
GOOGL
51
3
EXR
20
-2
NWS
58
-6
HPE
63
6
BXP
38
-6
CAH
54
3
ED
40
-2
TDC
34
-2
FITB
50
-8
AEE
73
-3
HON
49
-9
PM
49
4
MA
53
7
SCHW
56
3
CHD
29
-3
IFF
33
-11
EFX
55
-3
FLR
33
-5
V
36
4
VIX
40
-12
GOOGL
51
3
EXR
20
-2
NWS
58
-6
HPE
63
6
BXP
38
-6
CAH
54
3
ED
40
-2
TDC
34
-2
Financhill
Back

Guidewire Software Vs. Kymera Therapeutics Industry Stock Comparison

Sell
50

GWRE
Guidewire Software

Last Price:
$213.33
Seasonality Move:
5.83%
Sell
39

KYMR
Kymera Therapeutics

Last Price:
$40.64
Seasonality Move:
-2.33%
Sell
50
Guidewire Software (GWRE) is a Sell

Is Guidewire Software a Buy, Sell or Hold?

  • The current Guidewire Software [GWRE] share price is $213.27. The Score for GWRE is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • GWRE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $40.62. The Score for KYMR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • KYMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GWRE Stock Price Chart

What is Guidewire Software's stock price today?

  • The Guidewire Software share price today is $213.27
    The current trend is moderately bullish and GWRE is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $40.62
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

GWRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 61.09 Buy
Relative Strength Index (14 RSI): 33.93 Sell
Chaikin Money Flow: -399549 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (219.67 - 227.97) Sell
Bollinger Bands (100): (194.97 - 235.73) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 11.58 Buy
Relative Strength Index (14 RSI): 33.78 Sell
Chaikin Money Flow: 484697 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.69 - 45.87) Sell
Bollinger Bands (100): (28.55 - 45.29) Buy

GWRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 222.54 Sell
20-day SMA: 222.74 Sell
50-day SMA: 231.56 Sell
200-day SMA: 203.22 Buy
8-day EMA: 197.56 Buy
20-day EMA: 131.76 Buy
50-day EMA: 67.26 Buy
200-day EMA: 19.17 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.53 Sell
20-day SMA: 44.25 Sell
50-day SMA: 44.48 Sell
200-day SMA: 39.27 Buy
8-day EMA: 37.55 Buy
20-day EMA: 25.15 Buy
50-day EMA: 12.86 Buy
200-day EMA: 3.67 Buy

Guidewire Software Earnings Growth & GWRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.16 per share, an increase this year of $1.12 per share, and an increase next year of $0.40 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.65 per share, and a decrease next year of $0.51 per share.

Guidewire Software Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):